chr20-44115947-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_020433.5(JPH2):​c.1728C>G​(p.Pro576Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.216 in 1,567,210 control chromosomes in the GnomAD database, including 38,820 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 3786 hom., cov: 32)
Exomes 𝑓: 0.22 ( 35034 hom. )

Consequence

JPH2
NM_020433.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.416

Publications

12 publications found
Variant links:
Genes affected
JPH2 (HGNC:14202): (junctophilin 2) Junctional complexes between the plasma membrane and endoplasmic/sarcoplasmic reticulum are a common feature of all excitable cell types and mediate cross talk between cell surface and intracellular ion channels. The protein encoded by this gene is a component of junctional complexes and is composed of a C-terminal hydrophobic segment spanning the endoplasmic/sarcoplasmic reticulum membrane and a remaining cytoplasmic domain that shows specific affinity for the plasma membrane. This gene is a member of the junctophilin gene family. Alternative splicing has been observed at this locus and two variants encoding distinct isoforms are described. [provided by RefSeq, Jul 2008]
JPH2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy 17
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • cardiomyopathy, dilated, 2E
    Inheritance: Unknown, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • dilated cardiomyopathy
    Inheritance: SD Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 20-44115947-G-C is Benign according to our data. Variant chr20-44115947-G-C is described in ClinVar as Benign. ClinVar VariationId is 137609.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.416 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.252 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JPH2NM_020433.5 linkc.1728C>G p.Pro576Pro synonymous_variant Exon 4 of 6 ENST00000372980.4 NP_065166.2 Q9BR39-1Q86VZ3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JPH2ENST00000372980.4 linkc.1728C>G p.Pro576Pro synonymous_variant Exon 4 of 6 5 NM_020433.5 ENSP00000362071.3 Q9BR39-1

Frequencies

GnomAD3 genomes
AF:
0.217
AC:
32982
AN:
151938
Hom.:
3774
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.256
Gnomad AMI
AF:
0.324
Gnomad AMR
AF:
0.151
Gnomad ASJ
AF:
0.235
Gnomad EAS
AF:
0.0679
Gnomad SAS
AF:
0.0827
Gnomad FIN
AF:
0.216
Gnomad MID
AF:
0.137
Gnomad NFE
AF:
0.228
Gnomad OTH
AF:
0.199
GnomAD2 exomes
AF:
0.170
AC:
29150
AN:
171214
AF XY:
0.168
show subpopulations
Gnomad AFR exome
AF:
0.254
Gnomad AMR exome
AF:
0.108
Gnomad ASJ exome
AF:
0.229
Gnomad EAS exome
AF:
0.0644
Gnomad FIN exome
AF:
0.219
Gnomad NFE exome
AF:
0.223
Gnomad OTH exome
AF:
0.190
GnomAD4 exome
AF:
0.215
AC:
304879
AN:
1415164
Hom.:
35034
Cov.:
37
AF XY:
0.211
AC XY:
148255
AN XY:
701612
show subpopulations
African (AFR)
AF:
0.255
AC:
8374
AN:
32798
American (AMR)
AF:
0.112
AC:
4441
AN:
39722
Ashkenazi Jewish (ASJ)
AF:
0.233
AC:
5950
AN:
25496
East Asian (EAS)
AF:
0.0477
AC:
1825
AN:
38260
South Asian (SAS)
AF:
0.0839
AC:
6984
AN:
83206
European-Finnish (FIN)
AF:
0.221
AC:
7950
AN:
35912
Middle Eastern (MID)
AF:
0.159
AC:
872
AN:
5474
European-Non Finnish (NFE)
AF:
0.234
AC:
256395
AN:
1095356
Other (OTH)
AF:
0.205
AC:
12088
AN:
58940
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
14221
28441
42662
56882
71103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8734
17468
26202
34936
43670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.217
AC:
33025
AN:
152046
Hom.:
3786
Cov.:
32
AF XY:
0.212
AC XY:
15785
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.256
AC:
10619
AN:
41458
American (AMR)
AF:
0.150
AC:
2298
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.235
AC:
817
AN:
3470
East Asian (EAS)
AF:
0.0677
AC:
349
AN:
5156
South Asian (SAS)
AF:
0.0828
AC:
399
AN:
4820
European-Finnish (FIN)
AF:
0.216
AC:
2289
AN:
10594
Middle Eastern (MID)
AF:
0.134
AC:
39
AN:
292
European-Non Finnish (NFE)
AF:
0.228
AC:
15504
AN:
67934
Other (OTH)
AF:
0.197
AC:
416
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1359
2718
4078
5437
6796
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
340
680
1020
1360
1700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.221
Hom.:
712
Bravo
AF:
0.215
Asia WGS
AF:
0.0860
AC:
298
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 18, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jan 19, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Pro576Pro in exon 4 of JPH2: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. It has been identified in 18.9% (1430/7580) of European American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs74352869). -

Hypertrophic cardiomyopathy 17 Benign:2
Jul 28, 2017
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hypertrophic cardiomyopathy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 18, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.96
DANN
Benign
0.55
PhyloP100
-0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74352869; hg19: chr20-42744587; COSMIC: COSV65902448; API